Ottawa – One of Health Canada’s mandates is to reduce the incidence of disease and conditions among Canadians. Many science and health experts research and monitor diseases and you’ll find many of their reports and publications in this section. You’ll find information about many diseases and conditions, including their symptoms and treatments. Because healthy lifestyle choices reduce the risk of …
Ottawa – The latest edition of Meds Pipeline Monitor, from the Patented Medicine Prices Review Board, provides stakeholders with a list of new medicines in the late stages of clinical evaluation that may significantly impact clinical practice or drug spending in the coming years. There were over 12,000 drugs in the pipeline in 2023, increasing by an average of 19% per …
Ottawa, ON | Health Canada No community has been left untouched by the toxic drug and overdose crisis. Its tragic impacts are felt among friends, families and neighbours. Too many Canadians have lost their lives to this public health crisis. Canada’s approach is focused on providing access to a full continuum of health care services and leveraging every tool at …
Ottawa – The Government of Canada is taking steps to implement the modernized Canadian Environmental Protection Act, 1999 (CEPA), which recognizes in its preamble that every individual in Canada has a right to a healthy environment as provided under CEPA. It also strengthens Canada’s chemicals management regime and increases transparency in the way it is administered. Through the strengthening of CEPA, …
Ottawa – Everyone in Canada deserves a health system that provides each of us with access to the services we need, when and where we need them. The availability and types of mental health and substance use supports can vary across Canada, which can lead to inconsistencies in quality and accessibility. To help address this challenge, Health Canada commissioned the …
Product description Brand name COMIRNATY that has been approved recently by Health Canada Company name BioNTech Manufacturing GmbH Ingredient mRNA encoding SARS-CoV-2 spike protein, 5’ [m27,3’-OGppp(m12’-O)ApG] cap, 110-nucleotide 3′ poly(A) tail with a 10-nucleotide linker sequence. This product (COMIRNATY) includes an update to the antigen composition (variant Omicron KP.2) and replaces COMIRNATY Omicron XBB.1.5 (raxtozinameran).
Ottawa – Several vaccines for COVID-19 are authorized and available for use in Canada. These include messenger ribonucleic acid (mRNA) vaccines (preferred) and a protein subunit vaccine. The XBB.1.5 vaccines are now the recommended products. Refer to Preparations authorized for use in Canada for more information. Novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
Ottawa – Health Canada has asked provinces to destroy remaining last year’s Covid-19 vaccines supplies. The agency is working to get updated shots, some time in in October, per Ontario’s health ministry. A ministry statement read: “Vaccines will be available once Ontario receives supply from Health Canada following their regulatory authorization of the new, updated vaccine formulation.” The federal government’s immunization guide …
KIRKLAND – Pfizer Canada ULC announced that Health Canada has approved PADCEV® (enfortumab vedotin) an antibody-drug conjugate (ADC) in combination with pembrolizumab, a PD-1 inhibitor, for the treatment of adult patients with unresectable locally advanced or metastatic urothelial cancer (la/mUC) with no prior systemic therapy for mUC. The approval was made under the Health Canada Priority Review process, after having met the …
Ottawa – Every person in Canada deserves to age with dignity, safety, and comfort, regardless of where they live. While many Canadians want to age in their own home, they also expect and deserve that high quality long-term care options are available. That is why the Government of Canada is developing a Safe Long-Term Care Act. Health Canada released the …
